Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹-104 Cr₹-75 Cr₹124 Cr₹193 Cr₹237 Cr
Adjustment ₹250 Cr₹184 Cr₹138 Cr₹121 Cr₹87 Cr
Changes In working Capital ₹55 Cr₹2.79 Cr₹-88 Cr₹-73 Cr₹-109 Cr
Cash Flow after changes in Working Capital ₹201 Cr₹111 Cr₹173 Cr₹240 Cr₹215 Cr
Cash Flow from Operating Activities ₹192 Cr₹95 Cr₹155 Cr₹179 Cr₹174 Cr
Cash Flow from Investing Activities ₹-102 Cr₹-339 Cr₹-433 Cr₹-208 Cr₹-121 Cr
Cash Flow from Financing Activities ₹-77 Cr₹241 Cr₹280 Cr₹23 Cr₹-44 Cr
Net Cash Inflow / Outflow ₹14 Cr₹-2.75 Cr₹3.31 Cr₹-6.54 Cr₹8.05 Cr
Opening Cash & Cash Equivalents ₹12 Cr₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations --₹0.62 Cr--
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹26 Cr₹12 Cr₹15 Cr₹11 Cr₹17 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,994.6 Cr 0.1% -12.3% -22.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,831.0 Cr 2% 6% -6.7% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.1%

-12.3%

-22.8%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses